These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11127043)

  • 1. [Serum markers for trisomy 21 risk: value and limits].
    Muller F
    Gynecol Obstet Fertil; 2000 Nov; 28(11):844-6. PubMed ID: 11127043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for Down's syndrome. Serum screening programmes are effective and safe.
    Wald NJ; Hackshaw AK; Huttly W
    BMJ; 2000 Sep; 321(7263):763-4; author reply 764-5. PubMed ID: 10999927
    [No Abstract]   [Full Text] [Related]  

  • 4. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncation limits for CT marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2007 Feb; 27(2):187-8. PubMed ID: 17266161
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fetal trisomy 21 risk evaluation by measurement of maternal serum markers].
    Dhondt JL
    Ann Biol Clin (Paris); 1998; 56(4):471-5. PubMed ID: 9754284
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimising prenatal diagnosis of Down's syndrome.
    Neilson JP; Alfirevic Z
    BMJ; 2006 Feb; 332(7539):433-4. PubMed ID: 16497734
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in maternal serum screening for Down syndrome.
    Messerlian GM; Canick JA
    Med Health R I; 2002 Dec; 85(12):362-5. PubMed ID: 12593353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-marker screening for Down syndrome.
    Viner G
    CMAJ; 1996 Aug; 155(3):272; author reply 272-3. PubMed ID: 8705902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prenatal diagnosis for trisomy 21: triple test more efficient than age criterion].
    Beekhuis JR; Mantingh A
    Ned Tijdschr Geneeskd; 1997 Jan; 141(1):63. PubMed ID: 9162857
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 14. Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers.
    Hackshaw AK; Wald NJ
    Prenat Diagn; 2001 Jan; 21(1):58-61. PubMed ID: 11180243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value and drawbacks of evaluation of the risk of fetal trisomy 21].
    Taieb J; Benattar C; Audibert F; Frydman R; Lindenbaum A
    Contracept Fertil Sex; 1997 Apr; 25(4):269-76. PubMed ID: 9229515
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical screening for congenital defects.
    Bahado-Singh RO; Sutton-Riley J
    Obstet Gynecol Clin North Am; 2004 Dec; 31(4):857-72, xi. PubMed ID: 15550339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-marker screening for Down syndrome.
    Farrell SA; Chadwick DE; Summers AM; Wyatt PR
    CMAJ; 1996 Aug; 155(3):271-2; author reply 272-3. PubMed ID: 8705901
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
    Skotko B
    Obstet Gynecol; 2006 May; 107(5):1170. PubMed ID: 16648429
    [No Abstract]   [Full Text] [Related]  

  • 20. Combining first and second trimester markers for Down syndrome screening: think twice.
    Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.